Our use of cookies
We would like to use necessary cookies to perform the basic functions of this website. Such strictly necessary cookies do not require your consent and are therefore always active. We would also like to set analytical cookies and advertising cookies that help us make improvements by measuring how you use our website. Both the analytical cookies and advertising cookies require your consent and are therefore called “optional cookies”. Detailed information about the use of cookies and how you can control your consent for optional cookies can be found in our Cookie Policy and Privacy Policy.

Hello! We use cookies to help improve your experience of our website. With your consent, statistical and analytical cookies may also be used on this website. If you agree to the use of these additional cookies, please mark your choice:
H6JF21FpSTSqgGV5XcsI0pEW0wmDB03WrQEADlwr.png

10.07.2023

MGI's DNBSEQ-T20*x2 Wins 2023 Globee® Awards for Medical Equipment

Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.

tee273xLNe5MxMB1M5HxuFKGYQkhuK4KthVmXMGS.jpg

14.06.2023

Unveiling MGI's Groundbreaking Innovations at the ESHG Conference in Glasgow

Discover the groundbreaking partnerships and innovations unveiled by MGI Tech Co., Ltd. at the ESHG Conference in Glasgow. Learn about MGI's strategic collaborations in the European life sciences market, their advancements in sequencing and automation technologies, and their commitment to revolutionizing genomics research. This post also highlights MGI's strategic partnership with Alithea Genomics, aiming to innovate in RNA sequencing.

g8CwIb0BTQfR9HWerDbL53gOhfwhIAzhDTZw6aXK.jpg

09.06.2023

MGI and AddLife AB: A Strategic Collaboration to Revolutionize Life Science in the Nordic Region

Discover the strategic collaboration between MGI Tech Co. Ltd., a global leader in life science technology, and AddLife AB, a major European distributor of clinical testing and laboratory equipment. Learn how this partnership aims to revolutionize life science in the Nordic region through the distribution of MGI's innovative products and expansion into fields like point-of-care testing and remote ultrasound.

3IpC9cVNmUHebIjvmqXRG1UwP0GUyd2mKWcjLuIj.jpg

12.05.2023

MGI's DNBSEQ-T20×2* Wins BEYOND Healthcare Innovation Award

MGI's award-winning DNBSEQ-T20×2* gene sequencing platform revolutionizes DNA sequencing in healthcare, offering unparalleled throughput and cost-efficiency for researchers and clinicians.

BHUW2i8JVrCms3M1FnuJLRsSZUJfcdLeJJ8UJfYQ.png

09.05.2023

Pioneering Microbiome Research with the Million Microbiome of Humans Project

Explore MGI Tech Co. Ltd.'s significant contributions to the Million Microbiome of Humans Project (MMHP), a collaborative effort aiming to construct a comprehensive microbiome map of the human body. This post highlights MGI's innovative sequencing technology, the importance of microbiome in human health, and the future of microbiomics in precision medicine. Discover how MGI is reshaping the future of microbiome research and healthcare.

JrMJoPeITU1voELNW4J6Jw6qfQ5F4YeoODKXm04o.jpg

08.05.2023

MGI Launches Overseas Production Line of DNBSEQ-G400* Sequencer in Latvia

MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents, marking a significant milestone in MGI's expansion into the European market.